Literature DB >> 22540378

Influence of polymer blends on the characterization of gliclazide--encapsulated into poly (ε-caprolactone) microparticles.

Nahla S Barakat1, Gamal A Shazly, Azza H Almedany.   

Abstract

Gliclazide (GLZ)-loaded microparticles made with a polymeric blend were prepared by a solvent evaporation technique. Organic solutions of two polymers, poly(ε-caprolactone) (PCL) and Eudragit RS (E RS) or ethyl cellulose (EC), in different weight ratios, and 33.3% of GLZ were prepared and dropped into aqueous solution of poly vinyl alcohol, in different experimental conditions, achieving drug-loaded microparticles. The obtained microparticles were characterized in terms of yield of production, shape, size, surface properties, drug content, and in vitro drug release behavior. The physical state of the drugs and the polymer was determined by scanning electron microscopy (SEM), Fourier transform infra red and differential scanning calorimetry. Following the in vitro release studies microparticles made from blends of polymer, PCL/E RS or EC showed slower drug release than microparticles made from single PCL polymer. Surface morphology also revealed presence of porous and spherical structure of microparticles. Microparticles showing sustained release of GLZ were examined in rabbits and plasma GLZ concentrations were calculated using HPLC method of assay.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22540378     DOI: 10.3109/03639045.2012.681383

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  3 in total

1.  Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: a characterization study.

Authors:  Armin Mooranian; Rebecca Negrulj; Nigel Chen-Tan; Hesham S Al-Sallami; Zhongxiang Fang; Trilochan Mukkur; Momir Mikov; Svetlana Golocorbin-Kon; Marc Fakhoury; Frank Arfuso; Hani Al-Salami
Journal:  Drug Des Devel Ther       Date:  2014-07-28       Impact factor: 4.162

2.  Stability and Release Kinetics of an Advanced Gliclazide-Cholic Acid Formulation: The Use of Artificial-Cell Microencapsulation in Slow Release Targeted Oral Delivery of Antidiabetics.

Authors:  Armin Mooranian; Rebecca Negrulj; Sangeetha Mathavan; Jorge Martinez; Jessica Sciarretta; Nigel Chen-Tan; Tk Mukkur; Momir Mikov; Mladena Lalic-Popovic; Maja Stojančević; Svetlana Golocorbin-Kon; Hani Al-Salami
Journal:  J Pharm Innov       Date:  2014       Impact factor: 2.750

3.  A second-generation micro/nano capsules of an endogenous primary un-metabolised bile acid, stabilized by Eudragit-alginate complex with antioxidant compounds.

Authors:  Armin Mooranian; Nassim Zamani; Momir Mikov; Svetlana Goločorbin-Kon; Goran Stojanovic; Frank Arfuso; Bozica Kovacevic; Hani Al-Salami
Journal:  Saudi Pharm J       Date:  2019-12-07       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.